Skip to Page Content
ABOM Exam Preparation Packages
Collapse 2017 ABOM Exam Prep Bundle

This product is designed specifically as a study aid for the ABOM's Certification Examination for Obesity Medicine Physicians. It contains the most recent Review Course for the ABOM Exam (the content of which is based on the ABOM's published Test Content Outline) as well as supplemental courses on the four main treatment pillars (nutrition, behavior, physical activity, and medication) used to create individualized treatment plans for patients affected by obesity. 

 

The presentations within the 2017 ABOM Exam Prep Bundle can be purchased together as a series, or individually by session:

 

  • To purchase the entire series, click the Add to Cart button located directly below the pricing, and proceed to checkout. This package is 10% less than the individual sessions option!
     
  • To purchase sessions within the series, click the Purchase Individual Sessions option and select the check boxes below the session(s) you would like to purchase. Once sessions are selected, an additional Add to Cart button will appear below the number of sessions selected, to the right of your screen, as well as at the bottom of the page. Click the Add to Cart button and proceed to checkout.

 

Accreditation: 
The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

 

The OMA designates this enduring material internet activity for a maximum of 33 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.

Formats Available: On-demand
Original Presentation Date: January 17, 2017
On-Demand Release Date: Available Now

Approved Credit:
  • Obesity Medicine Association: 33.00 AMA PRA Category 1 Credit(s)™, 33.00 Participation Credit(s)

  • More InfoMore Info 2017 ABOM Exam Prep Bundle
    Collapse ABOM Prep Bundle Supplement

    This product provides additional material based upon the content in the ABOM's published Test Content Outline that is not included in the 2017 ABOM Exam Prep Bundle (this material does overlap with presentations included in the 2016 ABOM Exam Prep Bundle). 

     

    The presentations within the ABOM Prep Bundle Supplement can be purchased together as a series, or individually by session:

     

    • To purchase the entire series, click the Add to Cart button located directly below the pricing, and proceed to checkout. This package is 10% less than the individual sessions option!
       
    • To purchase sessions within the series, click the Purchase Individual Sessions option and select the check boxes below the session(s) you would like to purchase. Once sessions are selected, an additional Add to Cart button will appear below the number of sessions selected, to the right of your screen, as well as at the bottom of the page. Click the Add to Cart button and proceed to checkout.

     

    Accreditation: 
    The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

     

    The OMA designates this enduring material internet activity for a maximum of 16.25 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.

    Formats Available: On-demand
    Original Presentation Date: March 01, 2017
    On-Demand Release Date: Available Now

    Approved Credit:
  • Obesity Medicine Association: 16.25 AMA PRA Category 1 Credit(s)™, 16.25 Participation Credit(s)

  • More InfoMore Info ABOM Prep Bundle Supplement
    ABOM Exam Preparation Individual Lectures
    Collapse Assessment and Evaluation (Fall 2016)
    Ursula Inge Ferguson, DO, FACOI, FOMA, Dipl. ABOM
    CME/CE Expiration Date: 09/15/2019*
    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

     

    Description: Dr. Ferguson discusses how to assemble an obesity-related physical along with selecting appropriate tests including lab, radiology, and other assessments.
     


    Disclosures (at time of recording):
    Speaker:

    • Ursula Inge Ferguson, DO, FACOI, FOMA, Dipl. ABOM: Nothing to disclose

    Planners:

    • Stan Anderson, MD: GlaxoSmithKline, LLC: Advisory Activities
    • Amy Arrow Articolo, DO, FACOOG: Novo Nordisk: Advisory Activities, Speakers Bureau
    • Deborah Bade Horn, DO, MPH, MFOMA: Novo Nordisk: Speakers Bureau, Honoraria, and  Advisory Activities; Orexigen Therapeutics, Inc.: Speakers Bureau, Honoraria, and Advisory Activities
    • Michael Bateman, DO: Mead Johnson: Speakers Bureau
    • Erin Chamberlin, MD, FAAFP, FOMA: Orexigen Therapeutics, Inc.: Speakers Bureau
    • Sarah Hallberg, DO, MS: Atkins Corporation: Advisory Activities
    • Thomas C. Varughese, MD: Orexigen Therapeutics, Inc.: Speaker’s Bureau
    • Eric C. Westman, MD, MHS, MFOMA: KE Diet: Advisory Board; Invoy Technologies, LLC: Advisory Board; Various Book Royalties
    • Nothing to Disclose: Michael Arata, MD; Sandra Christensen, MSN, ARNP, FOMA; Virginia Crawford, MD; Neelima Dachuri, MD; Krishna Doniparthi, MD, FOMA; U. Inge Ferguson, DO, FACOI, FOMA; Brent Gear, DO; Carl Knopke, MD, FOMA; Dana Mansell, CHCP; William McCarthy, MD, FOMA; Timothy J. McCormick, DO, MPH; William Jeffrey McDaniel, MD; Lauren Rieck; Stacy Schmidt, PhD; Laurie Traetow, CAE

     

    Accreditation: 


    The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

     

    The OMA designates this enduring material internet activity for a maximum of 0.75 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.


    Originally Recorded: 9/21/2016

    Formats Available: On-demand
    Original Presentation Date: November 09, 2016
    On-Demand Release Date: Available Now

    Approved Credit:
  • Obesity Medicine Association: 0.75 AMA PRA Category 1 Credit(s)™, 0.75 Participation Credit(s)

  • More InfoMore Info Assessment and Evaluation (Fall 2016)
    Collapse Behavioral and Psychosocial Diagnosis and Treatment (Fall 2016)
    Carl Knopke, MD, FOMA, Dipl. ABOM
    CME/CE Expiration Date: 09/15/2019*
    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

     

    Description: Dr. Knopke reviews common behavioral problems related to obesity and treatment plans to address these behaviors. 

     


    Disclosures (at time of recording):
    Speaker:

    • Carl Knopke, MD, FOMA, Dipl. ABOM
      • Novo Nordisk, Inc: Advisory Activities

    Planners:

    • Stan Anderson, MD: GlaxoSmithKline, LLC: Advisory Activities
    • Amy Arrow Articolo, DO, FACOOG: Novo Nordisk: Advisory Activities, Speakers Bureau
    • Deborah Bade Horn, DO, MPH, MFOMA: Novo Nordisk: Speakers Bureau, Honoraria, and  Advisory Activities; Orexigen Therapeutics, Inc.: Speakers Bureau, Honoraria, and Advisory Activities
    • Michael Bateman, DO: Mead Johnson: Speakers Bureau
    • Erin Chamberlin, MD, FAAFP, FOMA: Orexigen Therapeutics, Inc.: Speakers Bureau
    • Sarah Hallberg, DO, MS: Atkins Corporation: Advisory Activities
    • Thomas C. Varughese, MD: Orexigen Therapeutics, Inc.: Speaker’s Bureau
    • Eric C. Westman, MD, MHS, MFOMA: KE Diet: Advisory Board; Invoy Technologies, LLC: Advisory Board; Various Book Royalties
    • Nothing to Disclose: Michael Arata, MD; Sandra Christensen, MSN, ARNP, FOMA; Virginia Crawford, MD; Neelima Dachuri, MD; Krishna Doniparthi, MD, FOMA; U. Inge Ferguson, DO, FACOI, FOMA; Brent Gear, DO; Carl Knopke, MD, FOMA; Dana Mansell, CHCP; William McCarthy, MD, FOMA; Timothy J. McCormick, DO, MPH; William Jeffrey McDaniel, MD; Lauren Rieck; Stacy Schmidt, PhD; Laurie Traetow, CAE

    ---------------------------------------------------------------------------------------------------------------------------------------------------------------

    Accreditation: 


    The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

     

    The OMA designates this enduring material internet activity for a maximum of 1.0 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.


    Originally Recorded: 9/22/2016

    Formats Available: On-demand
    Original Presentation Date: October 14, 2016
    On-Demand Release Date: Available Now

    Approved Credit:
  • Obesity Medicine Association: 1 AMA PRA Category 1 Credit(s)™, 1 Participation Credit(s)

  • More InfoMore Info Behavioral and Psychosocial Diagnosis and Treatment (Fall 2016)
    Collapse Epidemiology and Determinants of Obesity (Fall 2016)
    Amy Arrow Articolo, DO, FACOOG, Dipl. ABOM
    CME/CE Expiration Date: 09/15/2019*
    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

     

    Description: Dr. Articolo defines obesity and discusses the genetic, environmental, and cultural factors associated with obesity.
     


    Disclosures (at time of recording):
    Speaker:

    • Amy Arrow Articolo, DO, FACOOG, Dipl. ABOM: Novo Nordisk, Speakers Bureau, Advisory Activities, Development of Educational Activities

    Planners:

    • Stan Anderson, MD: GlaxoSmithKline, LLC: Advisory Activities
    • Amy Arrow Articolo, DO, FACOOG: Novo Nordisk: Advisory Activities, Speakers Bureau
    • Deborah Bade Horn, DO, MPH, MFOMA: Novo Nordisk: Speakers Bureau, Honoraria, and  Advisory Activities; Orexigen Therapeutics, Inc.: Speakers Bureau, Honoraria, and Advisory Activities
    • Michael Bateman, DO: Mead Johnson: Speakers Bureau
    • Erin Chamberlin, MD, FAAFP, FOMA: Orexigen Therapeutics, Inc.: Speakers Bureau
    • Sarah Hallberg, DO, MS: Atkins Corporation: Advisory Activities
    • Thomas C. Varughese, MD: Orexigen Therapeutics, Inc.: Speaker’s Bureau
    • Eric C. Westman, MD, MHS, MFOMA: KE Diet: Advisory Board; Invoy Technologies, LLC: Advisory Board; Various Book Royalties
    • Nothing to Disclose: Michael Arata, MD; Sandra Christensen, MSN, ARNP, FOMA; Virginia Crawford, MD; Neelima Dachuri, MD; Krishna Doniparthi, MD, FOMA; U. Inge Ferguson, DO, FACOI, FOMA; Brent Gear, DO; Carl Knopke, MD, FOMA; Dana Mansell, CHCP; William McCarthy, MD, FOMA; Timothy J. McCormick, DO, MPH; William Jeffrey McDaniel, MD; Lauren Rieck; Stacy Schmidt, PhD; Laurie Traetow, CAE

    -----------------------------------------------------------------------------------------------------------------------------------------------------------------

    Accreditation: 


    The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

     

    The OMA designates this enduring material internet activity for a maximum of 0.75 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.


    Originally Recorded: 9/21/2016

    Formats Available: On-demand
    Original Presentation Date: November 08, 2016
    On-Demand Release Date: Available Now

    Approved Credit:
  • Obesity Medicine Association: 0.75 AMA PRA Category 1 Credit(s)™, 0.75 Participation Credit(s)

  • More InfoMore Info Epidemiology and Determinants of Obesity (Fall 2016)
    Collapse Nutrition: Parts 1 & 2 (Fall 2016)
    Ethan Lazarus, MD, Dipl. ABOM
    CME/CE Expiration Date: 09/15/2019*
    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

     

    Description: Dr. Lazarus discusses macro and micronutrients and their Dietary Reference Intakes (DRI) along with meal replacements and low-calorie diets.

     


    Disclosures (at time of recording):
    Speaker:

    • Ethan Lazarus, MD, Dipl. ABOM: Novo Nordisk, Inc: Speakers Bureau, Advisory Activities; Orexigen Therapeutics, Inc: Speakers Bureau; Eisai, Inc.: Speakers Bureau

    Planners:

    • Stan Anderson, MD: GlaxoSmithKline, LLC: Advisory Activities
    • Amy Arrow Articolo, DO, FACOOG: Novo Nordisk: Advisory Activities, Speakers Bureau
    • Deborah Bade Horn, DO, MPH, MFOMA: Novo Nordisk: Speakers Bureau, Honoraria, and  Advisory Activities; Orexigen Therapeutics, Inc.: Speakers Bureau, Honoraria, and Advisory Activities
    • Michael Bateman, DO: Mead Johnson: Speakers Bureau
    • Erin Chamberlin, MD, FAAFP, FOMA: Orexigen Therapeutics, Inc.: Speakers Bureau
    • Sarah Hallberg, DO, MS: Atkins Corporation: Advisory Activities
    • Thomas C. Varughese, MD: Orexigen Therapeutics, Inc.: Speaker’s Bureau
    • Eric C. Westman, MD, MHS, MFOMA: KE Diet: Advisory Board; Invoy Technologies, LLC: Advisory Board; Various Book Royalties
    • Nothing to Disclose: Michael Arata, MD; Sandra Christensen, MSN, ARNP, FOMA; Virginia Crawford, MD; Neelima Dachuri, MD; Krishna Doniparthi, MD, FOMA; U. Inge Ferguson, DO, FACOI, FOMA; Brent Gear, DO; Carl Knopke, MD, FOMA; Dana Mansell, CHCP; William McCarthy, MD, FOMA; Timothy J. McCormick, DO, MPH; William Jeffrey McDaniel, MD; Lauren Rieck; Stacy Schmidt, PhD; Laurie Traetow, CAE

    -----------------------------------------------------------------------------------------------------------------------------------------------------------------

    Accreditation: 


    The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

     

    The OMA designates this enduring material internet activity for a maximum of 1.5 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.


    Originally Recorded: 9/21/2016

    Formats Available: On-demand
    Original Presentation Date: October 14, 2016
    On-Demand Release Date: Available Now

    Approved Credit:
  • Obesity Medicine Association: 1.50 AMA PRA Category 1 Credit(s)™, 1.50 Participation Credit(s)

  • More InfoMore Info Nutrition: Parts 1 & 2 (Fall 2016)
    Collapse Obesity Medicine Treatment Strategies (Fall 2016)
    Sarah Hallberg, DO, MS, Dipl. ABOM
    CME/CE Expiration Date: 09/15/2019*
    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

     

    Description: Dr. Hallberg discusses different treatment strategies along with managing weight plateaus and co-morbid conditions.

     


    Disclosures (at time of recording):
    Speaker:

    • Sarah Hallberg, DO, MS, Dipl. ABOM
      • Arkins Corporation: Advisory Activities

    Planners:

    • Stan Anderson, MD: GlaxoSmithKline, LLC: Advisory Activities
    • Amy Arrow Articolo, DO, FACOOG: Novo Nordisk: Advisory Activities, Speakers Bureau
    • Deborah Bade Horn, DO, MPH, MFOMA: Novo Nordisk: Speakers Bureau, Honoraria, and  Advisory Activities; Orexigen Therapeutics, Inc.: Speakers Bureau, Honoraria, and Advisory Activities
    • Michael Bateman, DO: Mead Johnson: Speakers Bureau
    • Erin Chamberlin, MD, FAAFP, FOMA: Orexigen Therapeutics, Inc.: Speakers Bureau
    • Sarah Hallberg, DO, MS: Atkins Corporation: Advisory Activities
    • Thomas C. Varughese, MD: Orexigen Therapeutics, Inc.: Speaker’s Bureau
    • Eric C. Westman, MD, MHS, MFOMA: KE Diet: Advisory Board; Invoy Technologies, LLC: Advisory Board; Various Book Royalties
    • Nothing to Disclose: Michael Arata, MD; Sandra Christensen, MSN, ARNP, FOMA; Virginia Crawford, MD; Neelima Dachuri, MD; Krishna Doniparthi, MD, FOMA; U. Inge Ferguson, DO, FACOI, FOMA; Brent Gear, DO; Carl Knopke, MD, FOMA; Dana Mansell, CHCP; William McCarthy, MD, FOMA; Timothy J. McCormick, DO, MPH; William Jeffrey McDaniel, MD; Lauren Rieck; Stacy Schmidt, PhD; Laurie Traetow, CAE

    Accreditation: 
    The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

     

    The OMA designates this enduring material internet activity for a maximum of 0.75 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.


    Originally Recorded: 9/21/2016

    Formats Available: On-demand
    Original Presentation Date: November 09, 2016
    On-Demand Release Date: Available Now

    Approved Credit:
  • Obesity Medicine Association: 0.75 AMA PRA Category 1 Credit(s)™, 0.75 Participation Credit(s)

  • More InfoMore Info Obesity Medicine Treatment Strategies (Fall 2016)
    Collapse Pathophysiology: Parts 1 & 2 (Fall 2016)
    Jeffrey Sicat, MD, FACE, Dipl. ABOM
    CME/CE Expiration Date: 09/15/2019*
    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

     

    Description:  Dr. Sicat reviews peripheral and CNS hormones along with the functions of different types of body fat and the impact of their distribution.

     


    Disclosures (at time of recording):
    Speaker:

    • Jeffrey Sicat, MD, FACE, Dipl. ABOM
      • Orexigen Therapeutics, Inc: Speakers Bureau, Advisory Activities
      • Novo Nordisk, Inc: Speakers Bureau, Advisory Activties
      • Eisai, Inc: Speakers Bureau

    Planners:

    • Stan Anderson, MD: GlaxoSmithKline, LLC: Advisory Activities
    • Amy Arrow Articolo, DO, FACOOG: Novo Nordisk: Advisory Activities, Speakers Bureau
    • Deborah Bade Horn, DO, MPH, MFOMA: Novo Nordisk: Speakers Bureau, Honoraria, and  Advisory Activities; Orexigen Therapeutics, Inc.: Speakers Bureau, Honoraria, and Advisory Activities
    • Michael Bateman, DO: Mead Johnson: Speakers Bureau
    • Erin Chamberlin, MD, FAAFP, FOMA: Orexigen Therapeutics, Inc.: Speakers Bureau
    • Sarah Hallberg, DO, MS: Atkins Corporation: Advisory Activities
    • Thomas C. Varughese, MD: Orexigen Therapeutics, Inc.: Speaker’s Bureau
    • Eric C. Westman, MD, MHS, MFOMA: KE Diet: Advisory Board; Invoy Technologies, LLC: Advisory Board; Various Book Royalties
    • Nothing to Disclose: Michael Arata, MD; Sandra Christensen, MSN, ARNP, FOMA; Virginia Crawford, MD; Neelima Dachuri, MD; Krishna Doniparthi, MD, FOMA; U. Inge Ferguson, DO, FACOI, FOMA; Brent Gear, DO; Carl Knopke, MD, FOMA; Dana Mansell, CHCP; William McCarthy, MD, FOMA; Timothy J. McCormick, DO, MPH; William Jeffrey McDaniel, MD; Lauren Rieck; Stacy Schmidt, PhD; Laurie Traetow, CAE

    Accreditation: 
    The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

     

    The OMA designates this enduring material internet activity for a maximum of 2.50 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.


    Originally Recorded: 9/22/2016

    Formats Available: On-demand
    Original Presentation Date: November 09, 2016
    On-Demand Release Date: Available Now

    Approved Credit:
  • Obesity Medicine Association: 2.50 AMA PRA Category 1 Credit(s)™, 2.50 Participation Credit(s)

  • More InfoMore Info Pathophysiology: Parts 1 & 2 (Fall 2016)
    Collapse Pediatrics (Fall 2016)
    Suzanne Cuda, MD, FAAP, FOMA, Dipl. ABOM
    CME/CE Expiration Date: 09/15/2019*
    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

     

    Description:  In Pediatrics (Parts 1 and 2), Dr. Cuda will review the epidemiology and risk factors for childhood obesity including environmental influences, 2007 Expert Committee Recommendations and flow charts in detail, as well as how to evaluate and treat children affected by obesity.

     

    -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

    Disclosures (at time of recording):
    Speaker:

    • Suzanne Cuda, MD, FAAP, FOMA, Dipl. ABOM: Nothing to disclose

    Planners:

    • Stan Anderson, MD: GlaxoSmithKline, LLC: Advisory Activities
    • Amy Arrow Articolo, DO, FACOOG: Novo Nordisk: Advisory Activities, Speakers Bureau
    • Deborah Bade Horn, DO, MPH, MFOMA: Novo Nordisk: Speakers Bureau, Honoraria, and  Advisory Activities; Orexigen Therapeutics, Inc.: Speakers Bureau, Honoraria, and Advisory Activities
    • Michael Bateman, DO: Mead Johnson: Speakers Bureau
    • Erin Chamberlin, MD, FAAFP, FOMA: Orexigen Therapeutics, Inc.: Speakers Bureau
    • Sarah Hallberg, DO, MS: Atkins Corporation: Advisory Activities
    • Thomas C. Varughese, MD: Orexigen Therapeutics, Inc.: Speaker’s Bureau
    • Eric C. Westman, MD, MHS, MFOMA: KE Diet: Advisory Board; Invoy Technologies, LLC: Advisory Board; Various Book Royalties
    • Nothing to Disclose: Michael Arata, MD; Sandra Christensen, MSN, ARNP, FOMA; Virginia Crawford, MD; Neelima Dachuri, MD; Krishna Doniparthi, MD, FOMA; U. Inge Ferguson, DO, FACOI, FOMA; Brent Gear, DO; Carl Knopke, MD, FOMA; Dana Mansell, CHCP; William McCarthy, MD, FOMA; Timothy J. McCormick, DO, MPH; William Jeffrey McDaniel, MD; Lauren Rieck; Stacy Schmidt, PhD; Laurie Traetow, CAE

    Accreditation: 
    The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

     

    The OMA designates this enduring material internet activity for a maximum of 1.25 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.


    Originally Recorded: 9/22/2016

    Formats Available: On-demand
    Original Presentation Date: November 09, 2016
    On-Demand Release Date: Available Now

    Approved Credit:
  • Obesity Medicine Association: 1.25 AMA PRA Category 1 Credit(s)™, 1.25 Participation Credit(s)

  • More InfoMore Info Pediatrics (Fall 2016)
    Collapse Pharmacotherapy (Fall 2016)
    W. Scott Butsch, MD, MSc, Dipl. ABOM
    CME/CE Expiration Date: 09/15/2019*
    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

     

    Description: Dr. Butsch discusses current FDA-approved and off-label anti-obesity medications along with their efficacy, indications, contraindications, and safety.

     


    Disclosures (at time of recording):
    Speaker:

    • W. Scott Butsch, MD, MSc, Dipl. ABOM: Nothing to disclose

    Planners:

    • Stan Anderson, MD: GlaxoSmithKline, LLC: Advisory Activities
    • Amy Arrow Articolo, DO, FACOOG: Novo Nordisk: Advisory Activities, Speakers Bureau
    • Deborah Bade Horn, DO, MPH, MFOMA: Novo Nordisk: Speakers Bureau, Honoraria, and  Advisory Activities; Orexigen Therapeutics, Inc.: Speakers Bureau, Honoraria, and Advisory Activities
    • Michael Bateman, DO: Mead Johnson: Speakers Bureau
    • Erin Chamberlin, MD, FAAFP, FOMA: Orexigen Therapeutics, Inc.: Speakers Bureau
    • Sarah Hallberg, DO, MS: Atkins Corporation: Advisory Activities
    • Thomas C. Varughese, MD: Orexigen Therapeutics, Inc.: Speaker’s Bureau
    • Eric C. Westman, MD, MHS, MFOMA: KE Diet: Advisory Board; Invoy Technologies, LLC: Advisory Board; Various Book Royalties
    • Nothing to Disclose: Michael Arata, MD; Sandra Christensen, MSN, ARNP, FOMA; Virginia Crawford, MD; Neelima Dachuri, MD; Krishna Doniparthi, MD, FOMA; U. Inge Ferguson, DO, FACOI, FOMA; Brent Gear, DO; Carl Knopke, MD, FOMA; Dana Mansell, CHCP; William McCarthy, MD, FOMA; Timothy J. McCormick, DO, MPH; William Jeffrey McDaniel, MD; Lauren Rieck; Stacy Schmidt, PhD; Laurie Traetow, CAE

    --------------------------------------------------------------------------------------------------------------------------------------------------------------

    Accreditation: 


    The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

     

    The OMA designates this enduring material internet activity for a maximum of 1.0 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.


    Originally Recorded: 9/22/2016

    Formats Available: On-demand
    Original Presentation Date: October 14, 2016

    Approved Credit:
  • Obesity Medicine Association: 1 AMA PRA Category 1 Credit(s)™, 1 Participation Credit(s)

  • More InfoMore Info Pharmacotherapy (Fall 2016)
    Collapse Physical Activity (Fall 2016)
    Deborah Bade Horn, DO, MPH, MFOMA, Dipl. ABOM
    CME/CE Expiration Date: 09/15/2019*
    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

     

    Description: Dr. Horn reviews the basics of creating an indvidualized exercise prescription along with the role physical activity has in weight loss.

     


    Disclosures (at time of recording):
    Speaker:

    • Deborah Bade Horn, DO, MPH, MFOMA, Dipl. ABOM
      • Novo Nordisk, Inc: Speakers Buraeu, Honoraria, and Advisory Activties
      • Orexigen Therapeutics, Inc: Speakers Bureau, Honorario, and Advisory Activities

    Planners:

    • Stan Anderson, MD: GlaxoSmithKline, LLC: Advisory Activities
    • Amy Arrow Articolo, DO, FACOOG: Novo Nordisk: Advisory Activities, Speakers Bureau
    • Deborah Bade Horn, DO, MPH, MFOMA: Novo Nordisk: Speakers Bureau, Honoraria, and  Advisory Activities; Orexigen Therapeutics, Inc.: Speakers Bureau, Honoraria, and Advisory Activities
    • Michael Bateman, DO: Mead Johnson: Speakers Bureau
    • Erin Chamberlin, MD, FAAFP, FOMA: Orexigen Therapeutics, Inc.: Speakers Bureau
    • Sarah Hallberg, DO, MS: Atkins Corporation: Advisory Activities
    • Thomas C. Varughese, MD: Orexigen Therapeutics, Inc.: Speaker’s Bureau
    • Eric C. Westman, MD, MHS, MFOMA: KE Diet: Advisory Board; Invoy Technologies, LLC: Advisory Board; Various Book Royalties
    • Nothing to Disclose: Michael Arata, MD; Sandra Christensen, MSN, ARNP, FOMA; Virginia Crawford, MD; Neelima Dachuri, MD; Krishna Doniparthi, MD, FOMA; U. Inge Ferguson, DO, FACOI, FOMA; Brent Gear, DO; Carl Knopke, MD, FOMA; Dana Mansell, CHCP; William McCarthy, MD, FOMA; Timothy J. McCormick, DO, MPH; William Jeffrey McDaniel, MD; Lauren Rieck; Stacy Schmidt, PhD; Laurie Traetow, CAE

    ----------------------------------------------------------------------------------------------------------------------------------------------------------------

    Accreditation: 


    The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

     

    The OMA designates this enduring material internet activity for a maximum of 1.0 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.


    Originally Recorded: 9/21/2016

    Formats Available: On-demand
    Original Presentation Date: October 14, 2016

    Approved Credit:
  • Obesity Medicine Association: 1 AMA PRA Category 1 Credit(s)™, 1 Participation Credit(s)

  • More InfoMore Info Physical Activity (Fall 2016)
    Collapse Practice Management (Fall 2016)
    Amy Arrow Articolo, DO, FACOOG, Dipl. ABOM
    CME/CE Expiration Date: 09/15/2019*
    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

     

    Description: Dr. Articolo addresses the issues and office policies and protocols related to treating a patient affected with obesity.

     


    Disclosures (at time of recording):
    Speaker: 

    • Amy Arrow Articolo, DO, FACOOG, Dipl. ABOM
      • Novo Nordisk: Speakers Bureau, Advisory Activities
      • Development of Educational Activities

    Planners:

    • Stan Anderson, MD: GlaxoSmithKline, LLC: Advisory Activities
    • Amy Arrow Articolo, DO, FACOOG: Novo Nordisk: Advisory Activities, Speakers Bureau
    • Deborah Bade Horn, DO, MPH, MFOMA: Novo Nordisk: Speakers Bureau, Honoraria, and  Advisory Activities; Orexigen Therapeutics, Inc.: Speakers Bureau, Honoraria, and Advisory Activities
    • Michael Bateman, DO: Mead Johnson: Speakers Bureau
    • Erin Chamberlin, MD, FAAFP, FOMA: Orexigen Therapeutics, Inc.: Speakers Bureau
    • Sarah Hallberg, DO, MS: Atkins Corporation: Advisory Activities
    • Thomas C. Varughese, MD: Orexigen Therapeutics, Inc.: Speaker’s Bureau
    • Eric C. Westman, MD, MHS, MFOMA: KE Diet: Advisory Board; Invoy Technologies, LLC: Advisory Board; Various Book Royalties
    • Nothing to Disclose: Michael Arata, MD; Sandra Christensen, MSN, ARNP, FOMA; Virginia Crawford, MD; Neelima Dachuri, MD; Krishna Doniparthi, MD, FOMA; U. Inge Ferguson, DO, FACOI, FOMA; Brent Gear, DO; Carl Knopke, MD, FOMA; Dana Mansell, CHCP; William McCarthy, MD, FOMA; Timothy J. McCormick, DO, MPH; William Jeffrey McDaniel, MD; Lauren Rieck; Stacy Schmidt, PhD; Laurie Traetow, CAE

    Accreditation: 
    The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

     

    The OMA designates this enduring material internet activity for a maximum of 0.5 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.


    Originally Recorded: 9/21/2016

    Formats Available: On-demand
    Original Presentation Date: November 09, 2016
    On-Demand Release Date: Available Now

    Approved Credit:
  • Obesity Medicine Association: 0.50 AMA PRA Category 1 Credit(s)™, 0.50 Participation Credit(s)

  • More InfoMore Info Practice Management (Fall 2016)
    Collapse Surgery (Fall 2016)
    Thomas W. Clark, MD, MS, FACS, FASMBS, Dipl. ABOM
    CME/CE Expiration Date: 09/15/2019*
    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

     

    Description: Dr. Clark discusses types of weight-loss surgery (WLS) procedures along with the risks and benefits assoicated with these procedures.

     


    Disclosures (at time of recording):
    Speaker:

    • Thomas W. Clark, MD, MS, FACS, FASMBS, Dipl. ABOM: Nothing to disclose

    Planners:

    • Stan Anderson, MD: GlaxoSmithKline, LLC: Advisory Activities
    • Amy Arrow Articolo, DO, FACOOG: Novo Nordisk: Advisory Activities, Speakers Bureau
    • Deborah Bade Horn, DO, MPH, MFOMA: Novo Nordisk: Speakers Bureau, Honoraria, and  Advisory Activities; Orexigen Therapeutics, Inc.: Speakers Bureau, Honoraria, and Advisory Activities
    • Michael Bateman, DO: Mead Johnson: Speakers Bureau
    • Erin Chamberlin, MD, FAAFP, FOMA: Orexigen Therapeutics, Inc.: Speakers Bureau
    • Sarah Hallberg, DO, MS: Atkins Corporation: Advisory Activities
    • Thomas C. Varughese, MD: Orexigen Therapeutics, Inc.: Speaker’s Bureau
    • Eric C. Westman, MD, MHS, MFOMA: KE Diet: Advisory Board; Invoy Technologies, LLC: Advisory Board; Various Book Royalties
    • Nothing to Disclose: Michael Arata, MD; Sandra Christensen, MSN, ARNP, FOMA; Virginia Crawford, MD; Neelima Dachuri, MD; Krishna Doniparthi, MD, FOMA; U. Inge Ferguson, DO, FACOI, FOMA; Brent Gear, DO; Carl Knopke, MD, FOMA; Dana Mansell, CHCP; William McCarthy, MD, FOMA; Timothy J. McCormick, DO, MPH; William Jeffrey McDaniel, MD; Lauren Rieck; Stacy Schmidt, PhD; Laurie Traetow, CAE

    Originally Recorded: 9/22/2016

    Formats Available: On-demand
    Original Presentation Date: November 04, 2016
    On-Demand Release Date: Available Now

    Approved Credit:
  • Obesity Medicine Association: 1.25 AMA PRA Category 1 Credit(s)™, 1.25 Participation Credit(s)

  • More InfoMore Info Surgery (Fall 2016)